These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26646548)

  • 1. Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease.
    Blyth CC; Jacoby P; Effler PV; Kelly H; Smith DW; Borland ML; Willis GA; Levy A; Keil AD; Richmond PC;
    Pediatr Infect Dis J; 2016 Mar; 35(3):309-15. PubMed ID: 26646548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of trivalent flu vaccine in healthy young children.
    Blyth CC; Jacoby P; Effler PV; Kelly H; Smith DW; Robins C; Willis GA; Levy A; Keil AD; Richmond PC;
    Pediatrics; 2014 May; 133(5):e1218-25. PubMed ID: 24753525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.
    Blyth CC; Cheng AC; Finucane C; Jacoby P; Effler PV; Smith DW; Kelly H; Macartney KK; Richmond PC
    Vaccine; 2015 Dec; 33(51):7239-7244. PubMed ID: 26549359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.
    Blyth CC; Richmond PC; Jacoby P; Thornton P; Regan A; Robins C; Kelly H; Smith DW; Effler PV
    Vaccine; 2014 Jul; 32(32):4075-81. PubMed ID: 24877764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.
    Blyth CC; Macartney KK; McRae J; Clark JE; Marshall HS; Buttery J; Francis JR; Kotsimbos T; Kelly PM; Cheng AC; ;
    Clin Infect Dis; 2019 Mar; 68(6):940-948. PubMed ID: 30137244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and Effectiveness of a Trivalent Inactivated Influenza Vaccine in Children in Urban and Rural Kenya, 2010 to 2012.
    Katz MA; Lebo E; Emukule GO; Otieno N; Caselton DL; Bigogo G; Njuguna H; Muthoka PM; Waiboci LW; Widdowson MA; Xu X; Njenga MK; Mott JA; Breiman RF
    Pediatr Infect Dis J; 2016 Mar; 35(3):322-9. PubMed ID: 26658627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine efficacy in young children attending childcare: A randomised controlled trial.
    Li-Kim-Moy JP; Yin JK; Heron L; Leask J; Lambert SB; Nissen M; Sloots T; Booy R
    J Paediatr Child Health; 2017 Jan; 53(1):47-54. PubMed ID: 27592696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study.
    Heinonen S; Silvennoinen H; Lehtinen P; Vainionpää R; Ziegler T; Heikkinen T
    Lancet Infect Dis; 2011 Jan; 11(1):23-9. PubMed ID: 21106443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Weil-Olivier C; Lina B
    Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oil-in-water emulsion adjuvant with influenza vaccine in young children.
    Vesikari T; Knuf M; Wutzler P; Karvonen A; Kieninger-Baum D; Schmitt HJ; Baehner F; Borkowski A; Tsai TF; Clemens R
    N Engl J Med; 2011 Oct; 365(15):1406-16. PubMed ID: 21995388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study.
    Joshi AY; Iyer VN; Hartz MF; Patel AM; Li JT
    Allergy Asthma Proc; 2012; 33(2):e23-7. PubMed ID: 22525386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
    Brady RC; Hu W; Houchin VG; Eder FS; Jackson KC; Hartel GF; Sawlwin DC; Albano FR; Greenberg M
    Vaccine; 2014 Dec; 32(52):7141-7. PubMed ID: 25454878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.
    Glanz JM; Newcomer SR; Hambidge SJ; Daley MF; Narwaney KJ; Xu S; Lee GM; Baggs J; Klein NP; Nordin JD; Naleway AL; Belongia EA; Weintraub ES
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):749-55. PubMed ID: 21810637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.
    Falkenhorst G; Harder T; Remschmidt C; Terhardt M; Zepp F; Ledig T; Wicker S; Keller-Stanislawski B; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1557-64. PubMed ID: 24170085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.